Global Xerostomia (Dry Mouth) Therapeutics Market Insight 2020, Forecast to 2030
- Report Code : WOR2018473
- Published On: Sep, 2020
- Category : Healthcare & Pharma
- Pages : 164
-
The Xerostomia (Dry Mouth) Therapeutics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Xerostomia (Dry Mouth) Therapeutics is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Xerostomia (Dry Mouth) Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Xerostomia (Dry Mouth) Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Xerostomia (Dry Mouth) Therapeutics market are discussed.
The market is segmented by types:
Salivary Stimulants
Salivary Substitutes
Dentifrices
It can be also divided by applications:
OTC
Prescription
And this report covers the historical situation, present status and the future prospects of the global Xerostomia (Dry Mouth) Therapeutics market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.
Finally, the report provides detailed profile and data information analysis of leading company.
GlaxoSmithKline plc
Church & Dwight Co., Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
Report Includes:
- xx data tables and xx additional tables
- An overview of global Xerostomia (Dry Mouth) Therapeutics market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Xerostomia (Dry Mouth) Therapeutics market
- Profiles of major players in the industry, including GlaxoSmithKline plc, Church & Dwight Co., Inc., Colgate-Palmolive Company, Hikma Pharmaceuticals PLC, Pendopharm..
Research Objectives
To study and analyze the global Xerostomia (Dry Mouth) Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Xerostomia (Dry Mouth) Therapeutics market by identifying its various subsegments.
Focuses on the key global Xerostomia (Dry Mouth) Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
To analyze the Xerostomia (Dry Mouth) Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Xerostomia (Dry Mouth) Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
-
With tables and figures helping analyze worldwide Global Xerostomia (Dry Mouth) Therapeutics market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Xerostomia (Dry Mouth) Therapeutics Market Report 2020, Forecast to 2025
1 Scope of the Study1.1 Xerostomia (Dry Mouth) Therapeutics Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Xerostomia (Dry Mouth) Therapeutics Industry Overview2.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Xerostomia (Dry Mouth) Therapeutics Global Import Market Analysis
2.1.2 Xerostomia (Dry Mouth) Therapeutics Global Export Market Analysis
2.1.3 Xerostomia (Dry Mouth) Therapeutics Global Main Region Market Analysis2.2 Market Analysis by Type
2.2.1 Salivary Stimulants
2.2.2 Salivary Substitutes
2.2.3 Dentifrices2.3 Market Analysis by Application
2.3.1 OTC
2.3.2 Prescription2.4 Global Xerostomia (Dry Mouth) Therapeutics Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Xerostomia (Dry Mouth) Therapeutics Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Xerostomia (Dry Mouth) Therapeutics Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Xerostomia (Dry Mouth) Therapeutics Manufacturer Market Share
2.4.5 Top 10 Xerostomia (Dry Mouth) Therapeutics Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Xerostomia (Dry Mouth) Therapeutics Market
2.4.7 Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Offered
2.4.8 Mergers & Acquisitions Planning2.5 Xerostomia (Dry Mouth) Therapeutics Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Xerostomia (Dry Mouth) Therapeutics Industry Impact
2.7.1 How the Covid-19 is Affecting the Xerostomia (Dry Mouth) Therapeutics Industry
2.7.2 Xerostomia (Dry Mouth) Therapeutics Business Impact Assessment - Covid-19
2.7.3 Market Trends and Xerostomia (Dry Mouth) Therapeutics Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 Upstream and Downstream Market Analysis3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Xerostomia (Dry Mouth) Therapeutics Manufacturing Cost Analysis3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Xerostomia (Dry Mouth) Therapeutics Market Size Categorized by Regions4.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue, Sales and Market Share by Regions
4.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Regions (2015-2020)4.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
4.3 APAC Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
4.4 North America Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
5 Europe Xerostomia (Dry Mouth) Therapeutics Market Size Categorized by Countries5.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2015-2020)
5.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2015-2020)
5.1.3 Germany Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
5.1.4 UK Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
5.1.5 France Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
5.1.6 Russia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
5.1.7 Italy Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
5.1.8 Spain Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)5.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
5.3.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue and Revenue Share by Type (2015-2020)5.4 Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
6 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Market Size Categorized by Countries6.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2015-2020)
6.1.3 China Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
6.1.4 Japan Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
6.1.5 Korea Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
6.1.6 India Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
6.1.8 Australia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)6.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue and Revenue Share by Type (2015-2020)6.4 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales and Market Share by Application (2015-2020)
7 North America Xerostomia (Dry Mouth) Therapeutics Market Size Categorized by Countries7.1 North America Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 North America Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2015-2020)
7.1.2 North America Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2015-2020)
7.1.3 United States Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
7.1.4 Canada Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
7.1.5 Mexico Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)7.2 North America Xerostomia (Dry Mouth) Therapeutics Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
7.3.2 North America Xerostomia (Dry Mouth) Therapeutics Revenue and Revenue Share by Type (2015-2020)7.4 North America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
8 South America Xerostomia (Dry Mouth) Therapeutics Market Size Categorized by Countries8.1 South America Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2015-2020)
8.1.2 South America Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2015-2020)
8.1.3 Brazil Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)8.2 South America Xerostomia (Dry Mouth) Therapeutics Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
8.3.2 South America Xerostomia (Dry Mouth) Therapeutics Revenue and Revenue Share by Type (2015-2020)8.4 South America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
9 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Market Size Categorized by Countries9.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2015-2020)
9.1.3 GCC Countries Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
9.1.4 Turkey Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
9.1.5 Egypt Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)
9.1.6 South Africa Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2015-2020)9.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue and Revenue Share by Type (2015-2020)9.4 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2015-2020)
10 Global Xerostomia (Dry Mouth) Therapeutics Market Segment by Type10.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales and Market Share by Type (2015-2020)
10.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Type (2015-2020)10.2 Salivary Stimulants Sales Growth Rate and Price
10.2.1 Global Salivary Stimulants Sales Growth Rate (2015-2020)
10.2.2 Global Salivary Stimulants Price (2015-2020)10.3 Salivary Substitutes Sales Growth Rate and Price
10.3.1 Global Salivary Substitutes Sales Growth Rate (2015-2020)
10.3.2 Global Salivary Substitutes Price (2015-2020)10.4 Dentifrices Sales Growth Rate and Price
10.4.1 Global Dentifrices Sales Growth Rate (2015-2020)
10.4.2 Global Dentifrices Price (2015-2020)
11 Global Xerostomia (Dry Mouth) Therapeutics Market Segment by Application11.1 Global Xerostomia (Dry Mouth) TherapeuticsSales Market Share by Application (2015-2020)
11.2 OTC Sales Growth Rate (2015-2020)
11.3 Prescription Sales Growth Rate (2015-2020)
12 Market Forecast for Xerostomia (Dry Mouth) Therapeutics12.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue, Sales and Growth Rate (2020-2025)
12.2 Xerostomia (Dry Mouth) Therapeutics Market Forecast by Regions (2020-2025)
12.2.1 Europe Xerostomia (Dry Mouth) Therapeutics Market Forecast (2020-2025)
12.2.2 APAC Xerostomia (Dry Mouth) Therapeutics Market Forecast (2020-2025)
12.2.3 North America Xerostomia (Dry Mouth) Therapeutics Market Forecast (2020-2025)
12.2.4 South America Xerostomia (Dry Mouth) Therapeutics Market Forecast (2020-2025)
12.2.5 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Market Forecast (2020-2025)12.3 Xerostomia (Dry Mouth) Therapeutics Market Forecast by Type (2020-2025)
12.3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2020-2025)
12.3.2 Global Xerostomia (Dry Mouth) Therapeutics Market Share Forecast by Type (2020-2025)12.4 Xerostomia (Dry Mouth) Therapeutics Market Forecast by Application (2020-2025)
12.4.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2020-2025)
12.4.2 Global Xerostomia (Dry Mouth) Therapeutics Market Share Forecast by Application (2020-2025)
13 Analysis of Xerostomia (Dry Mouth) Therapeutics Industry Key Manufacturers13.1 GlaxoSmithKline plc
13.1.1 Company Details
13.1.2 Product Information
13.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 GlaxoSmithKline plc News13.2 Church & Dwight Co., Inc.
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Church & Dwight Co., Inc. News13.3 Colgate-Palmolive Company
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Colgate-Palmolive Company News13.4 Hikma Pharmaceuticals PLC
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Hikma Pharmaceuticals PLC News13.5 Pendopharm
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Pendopharm News13.6 Sun Pharmaceuticals Industries Ltd.
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Sun Pharmaceuticals Industries Ltd. News
13.7 Lupin Pharmaceuticals, Inc.
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Lupin Pharmaceuticals, Inc. News
13.8 Pfizer, Inc.
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Pfizer, Inc. News
13.9 Parnell Pharmaceuticals, Inc.
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Parnell Pharmaceuticals, Inc. News13.10 Acacia Pharma
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Acacia Pharma News
13.11 OraCoat
13.11.1 Company Details
13.11.2 Product Information
13.11.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 OraCoat News
14 Research Findings and Conclusion
15 Appendix
-
The Global Xerostomia (Dry Mouth) Therapeutics Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
As manufacturers prepare to scale up, Global Xerostomia (Dry Mouth) Therapeutics companies must be clear and transparent about the impact of such volatility on the balance sheet.
Depending upon the type of applications, the Global Xerostomia (Dry Mouth) Therapeutics Market has been segmented into
During the projected year from 2024 to 2029, the Global Xerostomia (Dry Mouth) Therapeutics Market is expected to grow at a CAGR of xx%.
Yes, the add-on segmentation is available in the premium customised version of the Global Xerostomia (Dry Mouth) Therapeutics Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
The Global Xerostomia (Dry Mouth) Therapeutics study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.
